Molecular adapters in FcεRI signaling and the allergic response

Current Opinion in Immunology

Volumn 14, Issue 6, 2002, Pages 688-693

  Rivera, Juan ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ADHESION AND DEGRANULATION PROMOTING ADAPTER PROTEIN; CBL PROTEIN; CRK LIKE PROTEIN; FC RECEPTOR; GRB2 ASSOCIATED BINDER LIKE PROTEIN 2; GRB2 LIKE ADAPTER DOWNSTREAM OF SHC PROTEIN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; IMMUNOGLOBULIN E; LINKER FOR ACTIVATION OF T CELL PROTEIN; PROTEIN; PROTEIN 3BP2; PROTEIN 62 DOK; PROTEIN CLNK; PROTEIN MIST; PROTEIN NCK; PROTEIN SHC; PROTEIN VAV1; SH2 CONTAINING LEUKOCYTE SPECIFIC PROTEIN 76; UNCLASSIFIED DRUG; CARRIER PROTEIN; GAB2 PROTEIN, HUMAN; IMMUNOGLOBULIN E RECEPTOR; LAT PROTEIN, HUMAN; MEMBRANE PROTEIN; PHOSPHOPROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SLP 76 SIGNAL TRANSDUCING ADAPTOR PROTEINS; SLP-76 SIGNAL TRANSDUCING ADAPTOR PROTEINS;

ALLERGIC REACTION; BINDING AFFINITY; CELL ACTIVATION; KINETICS; MAST CELL; MOLECULAR DYNAMICS; MOLECULAR WEIGHT; NONHUMAN; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; HUMAN; HYPERSENSITIVITY; IMMUNOLOGY; MACROMOLECULE; PHYSIOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CARRIER PROTEINS; HUMANS; HYPERSENSITIVITY; MACROMOLECULAR SUBSTANCES; MAST CELLS; MEMBRANE PROTEINS; PHOSPHOPROTEINS; RECEPTORS, IGE; SIGNAL TRANSDUCTION;

EID: 0036888683     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(02)00396-5     Document Type: Review

References (51)

1. Nadler M.J., Matthews S.A., Turner H., Kinet J.-P. Signal transduction by the high-affinity immunoglobulin E receptor Fc epsilon RI: coupling form to function. Adv Immunol. 76:2000;325-355. A review with focus on structure and function relationship of the high affinity receptor for IgE. This is an excellent and relatively current source of IgE receptor signaling in mast cell activation.
2. Ott V.L., Cambier J.C. Activating and inhibitory signaling in mast cells: new opportunities for therapeutic intervention? J Allergy Clin Immunol. 106:2000;429-440. This review summarizes how inhibitory and activating receptors govern mast cell activation and the therapeutic implications in understanding how these receptors work.
3. Wedemeyer J., Tsai M., Galli S.J. Role of mast cells and basophils in innate and acquired immunity. Curr Opin Immunol. 12:2000;624-631. See annotation to [4•].
4. Gurish M.F., Austen K.F. The diverse roles of mast cells. J Exp Med. 194:2001;F1-F6. The above reviews [3•,4•] provide an excellent summary of the role of mast cells in health and disease and present a compelling argument for the physiological importance of mast cells in innate and acquired immunity.
5. Eiseman E., Bolen J.B. Engagement of the high-affinity IgE receptor activates src protein-related tyrosine kinases. Nature. 355:1992;78-80.
6. Vonakis B.M., Chen H.X., Haleem-Smith H., Metzger H. The unique domain as the site on Lyn kinase for its constitutive association with the high affinity receptor for IgE. J Biol Chem. 272:1997;24072-24080.
7. 2+ mobilization, but not degranulation, in Lyn-deficient bone marrow-derived mast cells. J Immunol. 158:1997;2350-2355.
8. Kawakami Y., Kitaura J., Satterthwaite A.B., Kato R.M., Asai K., Hartman S.E., Maeda-Yamamoto M., Lowell C.A., Rawlings D.J., Witte O.N., et al. Redundant and opposing functions of two tyrosine kinases, Btk and Lyn, in mast cell activation. J Immunol. 165:2000;1210-1219. Using Btk and Lyn-null mast cells the authors demonstrate a functional role for Btk in mast cell degranulation, whereas they find that Lyn is dispensable.
9. Parravicini V., Gadina M., Kovarova M., Odom S., Gonzalez-Espinosa C., Furumoto Y., Saitoh S., Samelson L.E., O'Shea J.J., Rivera J. Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nature Immunol. 3:2002;744-748. This paper reports that Fyn and not Lyn is required for mast cell degranulation. It also shows that Fyn regulates the Gab2-PI3K complex in mast cells and demonstrates the importance of this complex in support of PKC but not calcium signals.
10. Burack W.R., Cheng A.M., Shaw A.S. Scaffolds, adaptors and linkers of TCR signaling: theory and practice. Curr Opin Immunol. 14:2002;312-316.
11. Zhang W., Sloan-Lancaster J., Kitchen J., Trible R.P., Samelson L.E. LAT: the ZAP-70 tyrosine kinase substrate that links T cell receptor to cellular activation. Cell. 92:1998;83-92.
12. Saitoh S., Arudchandran R., Manetz T.S., Zhang W., Sommers C.L., Love P.E., Rivera J., Samelson L.E. LAT is essential for Fc(epsilon)RI-mediated mast cell activation. Immunity. 12:2000;525-535. The first report of a functional role for LAT in FcεRI-mediated mast cell degranulation. This study demonstrates the broad role of LAT in FcεRI-mediated mast cell activation.
13. Langlet C., Bernard A.-M., Drevot P., He H.-T. Membrane rafts and signaling by the multichain immune recognition receptors. Curr Opin Immunol. 12:2000;250-255.
14. Arudchandran R., Brown M.J., Peirce M.J., Song J.S., Zhang J., Siraganian R.P., Blank U., Rivera J. The Src homology 2 domain of Vav is required for its compartmentation to the plasma membrane and activation of c-jun NH(2)-terminal kinase 1. J Exp Med. 191:2000;47-60.
15. Zhang W., Trible R.P., Zhu M., Liu S.K., McGlade J., Samelson L.E. Association of Grb2, Gads, and phospholipase C-γ1 with phosphorylated LAT tyrosine residues. J Biol Chem. 275:2000;23355-23361.
16. Wilson B.S., Pfeiffer J.R., Surviladze Z., Gaudet E.A., Oliver J.M. High resolution mapping of mast cell membranes reveals primary and secondary domains of FcεRI and LAT. J Cell Biol. 154:2001;645-658. An elegant electron microscopic analysis of membrane-localized signaling proteins used by FcεRI. This study reveals that there are two distinct signaling domains formed by FcεRI aggregation and demonstrates that LAT and Gab2 are differentially partitioned in these domains.
17. Pasquet J.M., Gross B., Quek L., Asazuma N., Zhang W.G., Sommers C.L., Schweighoffer E., Tybulewicz V., Judd B., Lee J.R., et al. LAT is required for tyrosine phosphorylation of phospholipase Cgamma2 and platelet activation by the collagen receptor GPVI. Mol Cell Biol. 19:1999;8326-8334.
18. Bunnell S.C., Diehn M., Yaffe M.B., Findell P.R., Cantley L.C., Berg L.J. Biochemical interactions integrating Itk with the T cell receptor-initiated signaling cascade. J Biol Chem. 275:2000;2219-2230.
19. Scharenberg A.M., El-Hillal O., Fruman D.A., Beitz L.O., Li Z., Lin S., Gout I., Cantley L.C., Rawlings D.J., Kinet J.-P. Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. EMBO J. 17:1998;1961-1972.
20. Reynolds L.F., Smyth L.A., Norton T., Freshney N., Downward J., Kioussis D., Tybulewicz V.L.J. Vav1 transduces T cell receptor signals to the activation of phospholipase C-γ1 via phosphoinositide 3-kinase-dependent and -independent pathways. J Exp Med. 195:2002;1103-1114. See annotation to [36•].
21. Pivniouk V.I., Martin T.R., Lu-Kuo J.M., Katz H.R., Oettgen H.C., Geha R.S. SLP-76 deficiency impairs signaling via the high-affinity IgE receptor in mast cells. J Clin Invest. 103:1999;1737-1743.
22. Boerth N.J., Sadler J.J., Bauer D.E., Clements J.L., Gheith S.M., Koretzky G.A. Recruitment of SLP-76 to the membrane and glycolipid-enriched membrane microdomains replaces the requirement for linker for activation of T cells in T cell receptor signaling. J Exp Med. 192:2000;1047-1058. Using a chimeric SLP-76-LAT (transmembrane domain) construct expressed in LAT-deficient T cells the authors demonstrate that constitutive targeting of SLP-76 to the membrane reconstitutes many of the functions of LAT. This study shows that SLP-76 is critical to LAT-complex function.
23. Peterson E.J., Woods M.L., Dmowski S.A., Derimanov G., Jordan M.S., Wu J.N., Myung P.S., Liu Q.-H., Pribila J.T., Freedman B.D., et al. Coupling of the TCR to integrin activation by SLAP-130/Fyb. Science. 293:2001;2263-2265. See annotation to [25••].
24. Griffiths E.K., Krawczyk C., Kong Y.-Y., Raab M., Hyduk S.J., Bouchard D., Chan V.S., Kozieradzki I., Oliveira-dos-Santos A.J., Wakeham A., et al. Positive Regulation of T cell activation and integrin adhesion by the adapter Fyb/Slap. Science. 293:2001;2260-2262. See annotation to [25••].
25. Geng L., Pfister S., Kraeft S.K., Rudd C.E. Adaptor Fyb (Fyn-binding protein) regulates integrin mediated adhesion and mediator release: Differential involvement of the Fyb SH3 domain. Proc Natl Acad Sci USA. 98:2001;11527-11532. Papers [23••,24••] demonstrate that T cell activation, TCR-induced integrin clustering and integrin-mediated adhesion are defective in ADAP-deficient T cells. This paper [25••] demonstrates that ADAP overexpression can effectively modulate mast cell degranulation and adhesion and that the SH3 domain of ADAP is critical for the effect on degranulation.
26. Raab M., Kang H., Da Silva A., Zhu X.C., Rudd C.E. FYN-T-FYB-SLP-76 interactions define a T-cell receptor zeta/CD3-mediated tyrosine phosphorylation pathway that up-regulates interleukin 2 transcription in T-cells. J Biol Chem. 274:1999;21170-21179.
27. Ra C., Yasuda M., Yagita H., Okumura K. Fibronectin receptor integrins are involved in mast cell activation. J Allergy Clin Immunol. 94:1994;625-628.
28. Houtman R., Koster A.S., Nijkamp F.P. Integrin VLA-5: modulator and activator of mast cells. Clin Exp Allergy. 31:2001;817-822.
29. Schraven B., Marie-Cardine A., Koretzky G. Molecular analysis of the fyn-complex: cloning of SKAP55 and SLAP-130, two novel adaptor proteins which associate with fyn and may participate in the regulation of T cell receptor-mediated signaling. Immunol Lett. 57:1997;165-169.
30. Liu Y., Rohrschneider L.R. The gift of Gab. FEBS Lett. 515:2002;1-7.
31. Gu H., Saito K., Klaman L.D., Shen J., Fleming T., Wang Y., Pratt J.C., Lin G., Lim B., Kinet J.-P., et al. Essential role for Gab2 in the allergic response. Nature. 412:2001;186-190. This paper is the first report a phenotype for Gab2-deficiency and demonstrates the essential nature of Gab2 for PI3K activity and mast cell degranulation.
32. Xie Z.-H., Ambudkar I., Siraganian R.P. The adapter molecule Gab2 regulates FcεRI-mediated signal transduction in mast cells. J Immunol. 168:2002;4682-4691.
33. 2+ -independent isozymes of protein kinase C mediate exocytosis in antigen-stimulated rat basophilic RBL-2H3 cells. J Biol Chem. 268:1993;1749-1756.
34. Bustelo X.R. Regulatory and signaling properties of the Vav family. Mol Cell Biol. 20:2000;1461-1477.
35. Turner M., Billadeau D.D. Vav proteins as signal integrators for multi-subunit immune-recognition receptors. Nat Rev Immunol. 2:2002;476-486.
36. Manetz T.S., Gonzalez-Espinosa G., Arudchandran R., Xirasagar S., Tybulewicz V., Rivera J. Vav1 regulates phospholipase Cγ activation and calcium responses in mast cells. Mol Cell Biol. 21:2001;3763-3774. This paper demonstrates the requirement of Vav1 for PLCγ1 and PLCγ2 tyrosine phosphorylation and for IP3 and PIP3 production. Together with [20•] these studies provide compelling evidence for the role of Vav1 in the regulation of PLCγ activity via multiple mechanisms in which Vav1 participates.
37. 2+ mobilization in antigen-stimulated mast cells. J Leukoc Biol. 65:1999;321-329.
38. Le Good J.A., Ziegler W.H., Parekh D.B., Alessi D.R., Cohen P., Parker P.J. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science. 281:1998;2042-2045.
39. Torigoe C., Inman J.K., Metzger H. An unusual mechanism for ligand antagonism. Science. 281:1998;568-572.
40. Liu Z.-J., Haleem-Smith H., Chen H., Metzger H. Unexpected signals in a system subject to kinetic proofreading. Proc Natl Acad Sci USA. 98:2001;7289-7294. Using ligands (antigen) of low and high affinities the authors show that MCP-1 production, a late event in FcεRI-activated mast cells, escapes kinetic proofreading constraints. This study demonstrates that some signals can become independent and productive even when the presence of clustered and activated receptors is transient.
41. Hundley T.R., Prasad A.R., Beaven M.A. Elevated levels of cyclooxygenase-2 in antigen-stimulated mast cells is associated with minimal activation of p38 mitogen-activated protein kinase. J Immunol. 167:2001;1629-1636.
42. Sada K., Shahjahan Miah S.M., Maeno K., Kyo S., Qu X., Yamamura H. Regulation of FcεRI-mediated degranulation by an adaptor protein 3BP2 in the rat basophilic leukemia RBL-2H3 cells. Blood. 100:2002;2138-2144.
43. Ota Y., Beitz L.O., Scharenberg A.M., Donovan J.A., Kinet J.-P., Samelson L.E. Characterization of Cbl tyrosine phosphorylation and a Cbl-Syk complex in RBL-2H3 cells. J Exp Med. 184:1996;1713-1723.
44. Cao M.Y., Davidson D., Yu J., Latour S., Veillette A. Clnk, a novel SLP-76-related adaptor molecule expressed in cytokine-stimulated hemopoietic cells. J Exp Med. 190:1999;1527-1534.
45. Goitsuka R., Kanazashi H., Sasanuma H., Fujimura Y., Hidaka Y., Tatsuno Y., Ra C., Hayashi K., Kitamura D. A BASH/SLP-76-related adaptor protein MIST/Clnk involved in IgE receptor-mediated mast cell degranulation. Int Immunol. 12:2000;573-580.
46. Kyono W.T., de Jong R., Park R.K., Liu Y., Heisterkamp N., Groffen J., Durden D.L. Differential interaction of Crkl with Cbl or C3G, Hef-1, and gamma subunit immunoreceptor tyrosine-based activation motif in signaling of myeloid high affinity Fc receptor for IgG (Fc gamma RI). J Immunol. 161:1998;5555-5563.
47. dok, is a mediator of FcγRIIB inhibition of FcεRI signaling. J Immunol. 168:2002;4430-4439.
48. Liu S.K., McGlade C.J. Gads is a novel SH2 and SH3 domain-containing adaptor protein that binds to tyrosine-phosphorylated Shc. Oncogene. 17:1998;3073-3082.
49. Turner H., Reif K., Rivera J., Cantrell D.A. Regulation of the adapter molecule Grb2 by the FcεR1 in the mast cell line RBL2H3. J Biol Chem. 270:1995;9500-9506.
50. Hendricks-Taylor L.R., Motto D.G., Zhang J., Siraganian R.P., Koretzky G.A. SLP-76 is a substrate of the high affinity IgE receptor-stimulated protein tyrosine kinases in rat basophilic leukemia cells. J Biol Chem. 272:1997;1363-1367.
51. Houlard M., Arudchandran R., Regnier-Ricard F., Germani A., Gisselbrecht S., Blank U., Rivera J., Varin-Blank N. Vav1 is a component of transcriptionally active complexes. J Exp Med. 195:2002;1115-1127. This paper demonstrates that with prolonged FcεRI stimulation, Vav1 enters the nucleus of mast cells and is found complexed with transcriptionally active NFAT and NFκB.